|
1
|
Gill J, Ahluwalia MK, Geller D and Gorlick
R: New targets and approaches in osteosarcoma. Pharmacol Ther.
137:89–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ta HT, Dass CR, Choong PF and Dunstan DE:
Osteosarcoma treatment: state of the art. Cancer Metastasis Rev.
28:247–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li H, Min D, Zhao H, Wang Z, Qi W, Zheng
S, Tang L, He A, Sun Y, Yao Y and Shen Z: The prognostic role of
Ezrin immunoexpression in osteosarcoma: a meta-analysis of
published data. PLoS One. 8:e645132013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Y, Wu Y, Gu S, Sun Z, Rui Y, Wang J,
Lu Y, Li H, Xu K and Sheng P: Prognostic role of CD44 expression in
osteosarcoma: evidence from six studies. Diagn Pathol. 9:1402014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsukahara T, Kawaguchi S, Torigoe T,
Kimura S, Murase M, Ichimiya S, Wada T, Kaya M, Nagoya S, Ishii T,
et al: Prognostic impact and immunogenicity of a novel osteosarcoma
antigen, papillomavirus binding factor, in patients with
osteosarcoma. Cancer Sci. 99:368–375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Legrand G, Humez S, Slomianny C, Dewailly
E, Vanden Abeele F, Mariot P, Wuytack F and Prevarskaya N: Ca2+
pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases
2B involvement in human prostate cancer cell growth control. J Biol
Chem. 276:47608–47614. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thebault S, Flourakis M, Vanoverberghe K,
et al: Differential role of transient receptor potential channels
in Ca2+ entry and proliferation of prostate cancer epithelial
cells. Cancer Res. 66:2038–2047. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vanoverberghe K, Vanden Abeele F, Mariot
P, et al: Ca2+ homeostasis and apoptotic resistance of
neuroendocrine-differentiated prostate cancer cells. Cell Death
Differ. 11:321–330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Skryma R, Mariot P, Bourhis XL, et al:
Store depletion and store-operated Ca2+ current in human prostate
cancer LNCaP cells: involvement in apoptosis. J Physiol. 527:71–83.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaneko Y and Szallasi A: Transient
receptor potential (TRP) channels: a clinical perspective. Br J
Pharmacol. 171:2474–2507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen J, Luan Y, Yu R, Zhang Z, Zhang J and
Wang W: Transient receptor potential (TRP) channels, promising
potential diagnostic and therapeutic tools for cancer. Biosci
Trends. 8:1–10. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Knowlton WM and McKemy DD: TRPM8: From
cold to cancer, peppermint to pain. Curr Pharm Biotechnol.
12:68–77. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsavaler L, Shapero MH, Morkowski S and
Laus R: Trp-p8, a novel prostate-specific gene, is up-regulated in
prostate cancer and other malignancies and shares high homology
with transient receptor potential calcium channel proteins. Cancer
Res. 61:3760–3769. 2001.PubMed/NCBI
|
|
14
|
Kim SH, Nam JH, Park EJ, Kim BJ, Kim SJ,
So I and Jeon JH: Menthol regulates TRPM8-independent processes in
PC-3 prostate cancer cells. Biochim Biophys Acta. 1792:33–38. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chodon D, Guilbert A, Dhennin-Duthille I,
Gautier M, Telliez MS, Sevestre H and Ouadid-Ahidouch H: Estrogen
regulation of TRPM8 expression in breast cancer cells. BMC Cancer.
10:2122010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yee NS, Zhou W and Lee M: Transient
receptor potential channel TRPM8 is over-expressed and required for
cellular proliferation in pancreatic adenocarcinoma. Cancer Lett.
297:49–55. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao N, Jiang LM, Ge B, Zhang TY, Zhao XK
and Zhou X: Over-expression of TRPM8 is associated with poor
prognosis in urothelial carcinoma of bladder. Tumour Biol.
35:11499–11504. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Yang Z, Meng Z, Cao H, Zhu G, Liu
T and Wang X: Knockdown of TRPM8 suppresses cancer malignancy and
enhances epirubicin-induced apoptosis in human osteosarcoma cells.
Int J Biol Sci. 10:90–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spiessl B, Scheibe O and Wagner G: Soft
tissue sarcomas. In: International Union Against Cancer (UICC)
TNM-Atlas. Illustrated Guide to the Classification of Malignant
Tumours. Springer-Verlag. (Berlin). 170–172
|
|
20
|
Cianfrocca M and Goldstein LJ: Prognostic
and predictive factors in early-stage breast cancer. Oncologist.
9:606–616. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Greene FL, Stewart AK and Norton HJ: A new
TNM staging strategy for node-positive (stage III) colon cancer: an
analysis of 50,042 patients. Ann Surg. 236:416–421, (Discussion
421). 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jatoi I, Hilsenbeck SG, Clark GM and
Osborne CK: Significance of axillary lymph node metastasis in
primary breast cancer. J Clin Oncol. 17:2334–2340. 1999.PubMed/NCBI
|
|
23
|
Madu CO and Lu Y: Novel diagnostic
biomarkers for prostate cancer. J Cancer. 1:150–177. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Swanson RS, Compton CC, Stewart AK and
Bland KI: The prognosis of T3N0 colon cancer is dependent on the
number of lymph nodes examined. Ann Surg Oncol. 10:65–71. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rech A, Castro CG Jr, Mattei J, Gregianin
L, Di Leone L, David A, Rivero LF, Tarrago R, Abreu A and Brunetto
AL: Clinical features in osteosarcoma and prognostic implications.
J Pediatr (Rio J). 80:65–70. 2004.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Q, Wang X, Yang Z, Wang B and Li S:
Menthol induces cell death via the TRPM8 channel in the human
bladder cancer cell line T24. Oncology. 77:335–341. 2009.
View Article : Google Scholar : PubMed/NCBI
|
